NCT00199745

Differences in Atorvastatin Metabolite Ratios as a Diagnostic Tool in Detecting Atorvastatin Induced Myotoxicity

Investigations on Differences in Atorvastatin Metabolite Ratios as a Diagnostic Tool in Detecting Atorvastatin Induced Myotoxicity

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 53 (estimated)
• Sponsor: Oslo University Hospital · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

The primary objective of the study is to investigate whether differences in atorvastatin metabolite ratios might have a positive or negative predictive value in diagnosing atorvastatin muscle toxicity. A muscle biopsy is also collected and investigated.

Detailed description

The primary objective of the study is to investigate whether differences in atorvastatin metabolites ratios might have a positive or negative predictive value in diagnosing atorvastatin muscle toxicity. A muscle biopsy is also collected and investigated.

Conditions

• Muscular Diseases

Interventions

Type	Name	Description
DRUG	atorvastatin

Timeline

• Start date: 2005-10-01
• Primary completion: 2008-12-01
• Completion: 2008-12-01
• First posted: 2005-09-20
• Last updated: 2012-05-10

Locations

1 site across 1 country: Norway